North America
Boston 5

Our Local Leaders

Terry-2015-12-V2-Copy
Terence Shepherd, CM&AA, CPA, MST Principal, Founding Member
Carl Goldstein
Carl Goldstein, CPA Principal, Founding Member
Joe Vajda
Joseph J Vajda, MBA Senior Consultant
Jenn Moore
Jenn Moore Business Transition Consultant

Recent Projects

One of the first things prospective buyers look at is the strength of your management team. Our hands-on mentoring program is designed from an extensive SWOT analysis customized to each business.

Terry Shepherd – Managing Partner of ROCG’s Boston office recently wrote an article that was published by the Cape Business Journal. To read more click here…

Prior Events March 15, 2013

Click here to view past events and feel free to contact if you want to book these topics for your next event or trade association conference

See all recent Boston news/projects

Local Events

Panel discussion of the pros and cons of an internal sale to management, a transition to a family member(s), a sale to an outside company or venture capital funded group, or staying in the business while delegating more duties to management.

Our Local News

Long-delayed Cambridge condo project breaks ground

Needham-based Nauset Construction has broken ground on St. James Place, a long-delayed 46-unit condominium complex in Cambridge’s Porter Square neighborhood.  Acorn Holdings LLC is developing the project at 2013 Massachusetts Ave., a lot adjacent to St. James’s Episcopal Church that houses an out-of-use car wash. The project will also feature 2,000 square feet of retail and an 11,400-square-foot parish hall that will house classrooms for children’s programs, a library, a neighborhood food…

Needham's Verastem wins FDA approval for first cancer drug

The FDA has approved Needham biotech Verastem Oncology's first drug, a treatment for multiple types of blood cancer. The FDA on Monday gave the green light for sales of Copiktra, an oral medication designed to block two types of enzymes that fuel the growth and survival of malignant white blood cells. The drug has been approved for use in multiple types of blood cancers, including chronic lymphocytic leukemia and small lymphocytic lymphoma. The approval marks a major win for Verastem (Nasdaq: VSTM),…

Mass. uninsured population rises, but nearly all remain covered

At 97.2 percent, Massachusetts had the highest rate of insured residents, compared to the nationwide 91.3 percent.